Back to Business

Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting

Business September 17, 2026 at 7:52 PM

Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting

Investing.com

Read at Investing.com

More Stories

Spot gold set to snap three-day losing streak a day after Fed’s rate hike

Spot gold set to snap three-day losing streak a day after Fed’s rate hike

🇺🇸 Investing.com 36m ago

FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A

FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A

🇺🇸 Investing.com 38m ago

U.S. approves possible $24.3 billion F-35 sale to Saudi Arabia

U.S. approves possible $24.3 billion F-35 sale to Saudi Arabia

🇺🇸 Investing.com 40m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play